J4 ›› 2011, Vol. 37 ›› Issue (4): 641-645.

• 基础研究 • 上一篇    下一篇

氯化镉对人癌细胞株的抑制作用及其对细胞增殖核抗原和金属硫蛋白表达的影响

李 鹏1|卢日峰1|周英杰2|徐艳玲1|蔺新丽1|张 龙1|杜海英1   

  1. 1.吉林大学公共卫生学院卫生毒理学教研室|吉林 长春 130021;2.吉林大学公共卫
    生学院教科研办公室|吉林 长春 130021
  • 收稿日期:2011-04-15 出版日期:2011-07-28 发布日期:2011-07-28
  • 通讯作者: 杜海英(Tel:0431-85619153,E-mail:hydu@jlu.edu.cn) E-mail:hydu@jlu.edu.cn
  • 作者简介:李 鹏(1978-)|男|吉林省长春市人|中级实验师|在读医学硕士|主要从事病理生理学研究。
  • 基金资助:

    吉林省卫生厅重点实验室项目资助课题(2008Z030)

Inhibitory effects of cadmium chloride |on human cancer cells and influence in proliferation cell nuclear antigen and metallothionein expressions

LI Peng1,LU Ri-feng1,ZHOU Ying-jie2,XU Yan-ling1,LIN Xin-li1,
ZHANG Long1,DU Hai-ying1   

  1. 1.Department of Health Toxicology,School of Public Health,Jilin University,C
    hangchun 130021, China;2.Department of Teaching and Scientific Research,School of Public Health,Jilin University,Changchun 130021,China
  • Received:2011-04-15 Online:2011-07-28 Published:2011-07-28

摘要:

目的:研究氯化镉(CdCl2)抗肿瘤作用及其对细胞增殖核抗原(PCNA)和金属硫蛋白(MT)表达的影响,为其作为抗肿瘤药的开发利用提供理论依据。方法:以1、5、10、50和100  μmol·L-1 CdCl2作用于5种人癌细胞
株SMMC-7721、BEL-7402、Hela、A549和MCF7,24 h后应用MTT法检测抑瘤效应;以5、10、20、40和80 μmol·L-1CdCl2作用于SMMC-7721细胞24、48和72 h,MTT法检测时间-剂量-效应关系,SCGE法检测其对人肝癌细胞SMMC-7721的DNA损伤作用,应用免疫细胞化学法检测PCNA和MT的表达。结果:CdCl2对人肝癌SMMC-7721细胞半数抑制浓度最低(IC50=12.43 mL-1),随着CdCl2浓度增加和作用时间延长,40和80 μmol·L-1剂量组抑制作用逐渐增强,与对照组比较,差异有统计学意义(P<0.05),且存在时间-剂量-效应关系。与对照组比较,CdCl2作用12和24 h时,各剂量组SMMC-7721细胞DNA损伤率明显增加(P<0.05或P<0.01),但80 μmol·L-1组DNA损伤率反而下降;与对照组比较,各剂量组PCNA的表达明显下降(P<0.05或P<0.01);人肝癌细胞SMMC-7721中几乎不表达MT,CdCl2可诱导其MT的表达且具有剂量-效应关系。结论:CdCl2在体外具有显著的抗肿瘤效应,可能通过诱导DNA损伤、抑制PCNA蛋白的表达进而影响肿瘤细胞增殖;CdCl2可诱导MT产生部分拮抗作用。

关键词:  氯化镉;人肝癌细胞;细胞增殖核抗原;金属硫蛋白

Abstract:

Abstract:Objective To study the anti-tumor effects of cadmium chloride (CdCl2) and the influence in proliferating cell nuclear antigen (PCNA) and metallothionein(MT) expressions,and to  provide theoretical basis for development of CdCl2 as anti-tumor drug.Methods Five kinds of carcinoma cell lines,SMMC-7721,BEL-7402,Hela,A549 and MCF7 were treated with 1,5,10,50 and 100  μmol·L-1 CdCl2 for 24 h,MTT assay was used to measure the inhibitory rate. SMMC-7721 cells were treated with 5,10,20,40 and 80 μmol·L-1CdCl2 for 24,48 and 72 h,MTT assay was used to detect the time-dose-effect relationship.SCGE was applied to observe DNA damage.Immunocytochemistry assay was performed to detect positive expressions of PCNA and MT.Results The malignant hepatocarcinoma SMMC-7721 cell line showed a significant sensitivity to CaCl2 with a time-dose-effect relationship (IC50=12.43 m L-1).Compared with control group,the inhibitory rates in 40 and 80  μmol·L-1 groups were significantly decreased(P<0.01).Compared with  control  group,after treated with CdCl2 for 12 and 24 h,the DNA damage rates in CdCl2 groups were  increased(P<0.05 or P<0.01) with the increase of CdCl2 except for 80 μmol·L-1 group.Compared with control
 group,the expressions of PCNA in CdCl2 groups were  decreased (P<0.05 or P<0.01) with the increasing of CdCl2. SMMC-7721 could hardly express MT, but the expression could be induced by CdCl2 with a dose-effect relationship.Conclusion CdCl2 shows a significant anti-tumor effects in vitro,and  cause proliferation depression through inducing DNA damage and inhibiting PCNA protein expression,and its
 side effects may be alleviated by inducing MT expression.

Key words: cadmium chloride;human hepatocarcinoma cells;proliferating cell nuclear antigen;metallothionein

中图分类号: 

  •